The U.S. Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...

The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.

Just because information is available doesn’t mean it’s useful,” Dr. Deidre Popovich wrote in The Conversation.

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a ...

The FDA’s Friday announcement follows an announcement made March 10 by HHS that the agency is revisiting the GRAS final rule for potential reform. Three of the new chemicals that the FDA will study — ...

In a meta-analysis, both the 200-mg and 400-mg doses were effective, although the 400-mg dose was more effective in those with moderate-to-severe kidney disease.

The Food and Drug Administration (FDA) has cleared Lumipulse G for U.S. commercialization as the first blood-based test that ...

Trump is “in peak physical and mental condition,” White House Press Secretary Karoline Leavitt told The Atlantic in an ...

PHOENIX (AZFamily/AP) — The U.S. Food and Drug Administration has cleared the first blood test to help in the diagnosis of Alzheimer’s disease. The Alzheimer’s Association said on Friday the test ...

The FDA has cleared a new blood test that would significantly help in diagnosing patients with Alzheimer's disease. Unlike costly PET scans, this simple blood draw detects a key marker of Alzheimer’s.